Filing Flows › RXO (RXO) › Q2 2026 › vs Q2 2025
RXO (RXO) Q2 2026 vs Q2 2025 (year over year)
RXO's revenue rose $355M (+25%) from $1.4B in Q2 2025 to $1.8B in Q2 2026.
RXO, Q2 2026: revenue $1.8B (+25% year over year), operating margin 0.1%, net loss $9.0M, operating cash flow −$40.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8B | $1.4B | $355M | +25% |
| Net loss | $9.0M | $9.0M | $0 | 0% |
| Costs & expenses | $1.8B | $1.4B | $354M | +25% |
| Operating costs | $1.8B | $1.4B | $354M | +25% |
| Interest & other, net | $9.0M | $10.0M | −$1.0M | -10% |
| Income tax | $1.0M | −$1.0M | $2.0M | — |
| Cost of revenue | $1.5B | $1.1B | $354M | +32% |
| SG&A | $211M | $214M | −$3.0M | -1% |
| Other operating costs | $90.0M | $87.0M | $3.0M | +3% |
| Operating cash sources | $73.0M | $14.0M | $59.0M | +421% |
| Depreciation & amortization | $26.0M | $30.0M | −$4.0M | -13% |
| Share-based compensation | $7.0M | $7.0M | $0 | 0% |
| Cash used in operations | $40.0M | −$23.0M | $63.0M | — |
| Net loss absorbed | $9.0M | $9.0M | $0 | 0% |
| Working capital & other | $64.0M | $5.0M | $59.0M | 13× |
Questions
How much did RXO's revenue grow year over year in Q2 2026?
RXO's revenue rose $355M (+25%) from $1.4B in Q2 2025 to $1.8B in Q2 2026.